News
Public sector must develop drugs for neglected diseases
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7339.698/b (Published 23 March 2002) Cite this as: BMJ 2002;324:698
- Gavin Yamey
- Oakland
Western society's decision to leave drug development in the hands of the private sector has led to a crisis for the world's poor, because the private sector has failed to develop or distribute drugs to treat infectious diseases in the poorest regions of the world. A new public sector initiative is urgently needed to …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.